CoChat

Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data

Open access
Attaei, Marjan W, Khatib, Rasha, McKee, Martin, Lear, Scott, Dagenais, Gilles, Igumbor, Ehimario U, AlHabib, Khalid F, Kaur, Manmeet, Kruger, Lanthe, Teo, Koon, Lanas, Fernando, Yusoff, Khalid, Oguz, Aytekin, Gupta, Rajeev, Yusufali, Afzalhussein M, Bahonar, Ahmad, Kutty, Raman, Rosengren, Annika, Mohan, Viswanathan, Avezum, Alvaro, Yusuf, Rita, Szuba, Andrzej, Rangarajan, Sumathy, Chow, Clara, Yusuf, Salim, Yusuf, S, Rangarajan, S, Teo, K K, Chow, C K, O'Donnell, M, Mente, A, Leong, D, Smyth, A, Joseph, P, Islam, S, Zhang, M, Hu, W, Ramasundarahettige, C, Wong, G, Dayal, L, Casanova, A, Dehghan, M, Lewis, G, Aliberti, A, Reyes, A, Zaki, A, Lewis, B, Zhang, B, Agapay, D, Hari, D, Milazzo, E, Ramezani, E, Hussain, F, Shifaly, F, Kay, I, Rimac, J, Swallow, J, Heldman, L, Mushtaha, M(a), Mushtaha, M(o), Trottier, M, Aoucheva, N, Kandy, N, Mackie, P, Solano, R, Chin, S, Ramacham, S, Shahrook, S, Trottier, S, Tongana, T, ElSheikh, W, Lindeman, J, McQueen, M, Hall, K, Keys, J, Wang, X, Keneth, J, Devanath, A, Diaz, R, Orlandini, A, Linetsky, B, Toscanelli, S, Casaccia, G, Maini Cuneo, JM, Rahman, O, Yusuf, R, Azad, AK, Rabbani, KA, Cherry, HM, Mannan, A, Hassan, I, Talukdar, AT, Tooheen, RB, Khan, MU, Sintaha, M, Choudhury, T, Haque, R, Parvin, S, Avezum, A, Oliveira, GB, Marcilio, CS, Mattos, AC, Teo, K, Yusuf, S, Dejesus, J, Agapay, D, Tongana, T, Solano, R, Kay, I, Trottier, S, Rimac, J, Elsheikh, W, Heldman, L, Ramezani, E, Dagenais, G, Poirier, P, Turbide, G, Auger, D, De Bluts, A LeBlanc, Proulx, MC, Cayer, M, Bonneville, N, Lear, S, Gasevic, D, Corber, E, de Jong, V, Vukmirovich, I, Wielgosz, A, Fodor, G, Pipe, A, Shane, A, Lanas, F, Seron, P, Martinez, S, Valdebenito, A, Oliveros, M, Wei, Li, Lisheng, Liu, Chunming, Chen, Xingyu, Wang, Wenhua, Zhao, Hongye, Zhang, JiaXuan, Bo, Hu, Yi, Sun, Jian, Bo, Xiuwen, Zhao, Xiaohong, Chang, Tao, Chen, Hui, Chen, Xiaohong, Chang, Qing, Deng, Xiaoru, Cheng, Qing, Deng, Xinye, He, Bo, Hu, JiaXuan, Jian, Li, Juan, Li, Xu, Liu, Bing, Ren, Yi, Sun, Wei, Wang, Yang, Wang, Jun, Yang, Yi, Zhai, Hongye, Zhang, Xiuwen, Zhao, Manlu, Zhu, Fanghong, Lu, Jianfang, Wu, Yindong, Li, Yan, Hou, Liangqing, Zhang, Baoxia, Guo, Xiaoyang, Liao, Shiying, Zhang, BianRongwen, TianXiuzhen, Dong, Li, Di, Chen, Jianguo, Wu, Yize, Xiao, Tianlu, Liu, Peng, Zhang, Changlin, Dong, Ning, Li, Xiaolan, Ma, Yuqing, Yang, Rensheng, Lei, Minfan, Fu, Jing, He, Yu, Liu, Xiaojie, Xing, Qiang, Zhou, Lopez-Jaramillo, P, Lopez, PA Camacho, Garcia, R, Jurado, LJA, Gómez-Arbeláez, D, Arguello, JF, Dueñas, R, Silva, S, Pradilla, LP, Ramirez, F, Molina, DI, Cure-Cure, C, Perez, M, Hernandez, E, Arcos, E, Fernandez, S, Narvaez, C, Paez, J, Sotomayor, A, Garcia, H, Sanchez, G, David, T, Rico, A, Mony, P, Vaz, M, Bharathi, A V, Swaminathan, S, Shankar, K, Kurpad, AV, Jayachitra, KG, Kumar, N, Hospital, HAL, Mohan, V, Deepa, M, Parthiban, K, Anitha, M, Hemavathy, S, Rahulashankiruthiyayan, T, Anitha, D, Sridevi, K, Gupta, R, Panwar, RB, Mohan, I, Rastogi, P, Rastogi, S, Bhargava, R, Kumar, R, Thakur, J S, Patro, B, Lakshmi, PVM, Mahajan, R, Chaudary, P, Kutty, V Raman, Vijayakumar, K, Ajayan, K, Rajasree, G, Renjini, AR, Deepu, A, Sandhya, B, Asha, S, Soumya, HS, Kelishadi, R, Bahonar, A, Mohammadifard, N, Heidari, H, Yusoff, K, Ismail, TST, Ng, KK, Devi, A, Nasir, NM, Yasin, MM, Miskan, M, Rahman, EA, Arsad, MKM, Ariffin, F, Razak, SA, Majid, FA, Bakar, NA, Yacob, MY, Zainon, N, Salleh, R, Ramli, MKA, Halim, NA, Norlizan, SR, Ghazali, NM, Arshad, MN, Razali, R, Ali, S, Othman, HR, Hafar, CWJCW, Pit, A, Danuri, N, Basir, F, Zahari, SNA, Abdullah, H, Arippin, MA, Zakaria, NA, Noorhassim, I, Hasni, MJ, Azmi, MT, Zaleha, MI, Hazdi, KY, Rizam, AR, Sazman, W, Azman, A, Khatib, R, Khammash, U, Khatib, A, Giacaman, R, Iqbal, R, Afridi, A, Khawaja, R, Raza, A, Kazmi, K, Dans, A, Co, HU, Sanchez, JT, Pudol, L, Zamora-Pudol, C, Palileo-Villanueva, LAM, Aquino, MR, Abaquin, C, Pudol, SL, Cabral, ML, Zatonski, W, Szuba, A, Zatonska, K, Ilow#, R, Ferus, M, Regulska-Ilow, B, Różańska, D, Wolyniec, M, AlHabib, KF, Hersi, A, Kashour, T, Alfaleh, H, Alshamiri, M, Altaradi, HB, Alnobani, O, Bafart, A, Alkamel, N, Ali, M, Abdulrahman, M, Nouri, R, Kruger, A, Voster, H H, Schutte, A E, Wentzel-Viljoen, E, Eloff, FC, de Ridder, H, Moss, H, Potgieter, J, Roux, AA, Watson, M, de Wet, G, Olckers, A, Jerling, JC, Pieters, M, Hoekstra, T, Puoane, T, Igumbor, E, Tsolekile, L, Sanders, D, Naidoo, P, Steyn, N, Peer, N, Mayosi, B, Rayner, B, Lambert, V, Levitt, N, Kolbe-Alexander, T, Ntyintyane, L, Hughes, G, Swart, R, Fourie, J, Muzigaba, M, Xapa, S, Gobile, N, Ndayi, K, Jwili, B, Ndibaza, K, Egbujie, B, Rosengren, A, Boström, K Bengtsson, Lindblad, U, Langkilde, P, Gustavsson, A, Andreasson, M, Snällman, M, Wirdemann, L, Pettersson, K, Moberg, E, Yeates, K, Sleeth, J, Kilonzo, K, Oguz, A, Akalin, AAK, Calik, KBT, Imeryuz, N, Temizhan, A, Alphan, E, Gunes, E, Sur, H, Karsidag, K, Gulec, S, Altuntas, Y, Yusufali, AM, Almahmeed, W, Swidan, H, Darwish, EA, Hashemi, ARA, Al-Khaja, N, Muscat-Baron, JM, Ahmed, SH, Mamdouh, TM, Darwish, WM, Abdelmotagali, MHS, Awed, SA Omer, Movahedi, GA, Hussain, F, Shaibani, H Al, Gharabou, RIM, Youssef, DF, Nawati, AZS, Salah, ZAR Abu, Abdalla, RFE, Shuwaihi, SM Al, Omairi, MA Al, Cadigal, OD, Alejandrino, R.S., Chifamba, J, Gwaunza, L, Terera, G, Mahachi, C, Murambiwa, P, Machiweni, T, Mapanga, R · 2017 · The Lancet Public Health

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Hypertension is considered the most important risk factor for cardiovascular diseases, but its control is poor worldwide. We aimed to assess the availability and affordability of blood pressure-lowering medicines, and the association with use of these medicines and blood pressure control in countries at varying levels of economic development. METHODS: We analysed the availability, costs, and affordability of blood pressure-lowering medicines with data recorded from 626 communities in 20 countries participating in the Prospective Urban Rural Epidemiological (PURE) study. Medicines were considered available if they were present in the local pharmacy when surveyed, and affordable if their combined cost was less than 20% of the households' capacity to pay. We related information about availability and affordability to use of these medicines and blood pressure control with multilevel mixed-effects logistic regression models, and compared results for high-income, upper-middle-income, lower-middle-income, and low-income countries. Data for India are presented separately because it has a large generic pharmaceutical industry and a higher availability of medicines than other countries at the same economic level. FINDINGS: The availability of two or more classes of blood pressure-lowering drugs was lower in low-income and middle-income countries (except for India) than in high-income countries. The proportion of communities with four drug classes available was 94% in high-income countries (108 of 115 communities), 76% in India (68 of 90), 71% in upper-middle-income countries (90 of 126), 47% in lower-middle-income countries (107 of 227), and 13% in low-income countries (nine of 68). The proportion of households unable to afford two blood pressure-lowering medicines was 31% in low-income countries (1069 of 3479 households), 9% in middle-income countries (5602 of 65 471), and less than 1% in high-income countries (44 of 10 880). Participants with known hypertension in communities that had all four drug classes available were more likely to use at least one blood pressure-lowering medicine (adjusted odds ratio [OR] 2·23, 95% CI 1·59-3·12); p<0·0001), combination therapy (1·53, 1·13-2·07; p=0·054), and have their blood pressure controlled (2·06, 1·69-2·50; p<0·0001) than were those in communities where blood pressure-lowering medicines were not available. Participants with known hypertension from households able to afford four blood pressure-lowering drug classes were more likely to use at least one blood pressure-lowering medicine (adjusted OR 1·42, 95% CI 1·25-1·62; p<0·0001), combination therapy (1·26, 1·08-1·47; p=0·0038), and have their blood pressure controlled (1·13, 1·00-1·28; p=0·0562) than were those unable to afford the medicines. INTERPRETATION: A large proportion of communities in low-income and middle-income countries do not have access to more than one blood pressure-lowering medicine and, when available, they are often not affordable. These factors are associated with poor blood pressure control. Ensuring access to affordable blood pressure-lowering medicines is essential for control of hypertension in low-income and middle-income countries. FUNDING: Population Health Research Institute, the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, Canadian Institutes of Health Research Strategy for Patient Oriented Research through the Ontario SPOR Support Unit, the Ontario Ministry of Health and Long-Term Care, pharmaceutical companies (with major contributions from AstraZeneca [Canada], Sanofi Aventis [France and Canada], Boehringer Ingelheim [Germany amd Canada], Servier, and GlaxoSmithKline), Novartis and King Pharma, and national or local organisations in participating countries.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2468-2667(17)30141-x

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Availability of BP-lowering medicines in 626 PURE communities
Figure 1 Availability of BP-lowering medicines in 626 PURE communitiesCC-BY-NC-ND · From the PDF
Figure 2 Proportion of households that could not afford blood pressure-lowering medicines and combination therapy (n=98 785) With a 20% capacity-to-pay threshold. Error bars represent 95% CIs. HIC=high-income countries.
Figure 2 Proportion of households that could not afford blood pressure-lowering medicines and combination therapy (n=98 785) With a 20% capacity-to-pay threshold. Error bars represent 95% CIs. HIC=high-income countries.CC-BY-NC-ND · From the PDF
Figure 3 Associations between availability and affordability and use of at least one blood pressure-lowering medicine, combination therapy, and blood pressure control in participants with known hypertension (n=33 045)
Figure 3 Associations between availability and affordability and use of at least one blood pressure-lowering medicine, combination therapy, and blood pressure control in participants with known hypertension (n=33 045)CC-BY-NC-ND · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Cited by

See all 227

Metadata

Authors
Attaei, M. W., Khatib, R., McKee, M., Lear, S., Dagenais, G., Igumbor, E. U., AlHabib, K. F., Kaur, M., Kruger, L., Teo, K., Lanas, F., Yusoff, K., Oguz, A., Gupta, R., Yusufali, A. M., Bahonar, A., Kutty, R., Rosengren, A., Mohan, V., Avezum, A., Yusuf, R., Szuba, A., Rangarajan, S., Chow, C., Yusuf, S., Yusuf, S., Rangarajan, S., Teo, K. K., Chow, C. K., O'Donnell, M., Mente, A., Leong, D., Smyth, A., Joseph, P., Islam, S., Zhang, M., Hu, W., Ramasundarahettige, C., Wong, G., Dayal, L., Casanova, A., Dehghan, M., Lewis, G., Aliberti, A., Reyes, A., Zaki, A., Lewis, B., Zhang, B., Agapay, D., Hari, D., Milazzo, E., Ramezani, E., Hussain, F., Shifaly, F., Kay, I., Rimac, J., Swallow, J., Heldman, L., Mushtaha, M., Mushtaha, M., Trottier, M., Aoucheva, N., Kandy, N., Mackie, P., Solano, R., Chin, S., Ramacham, S., Shahrook, S., Trottier, S., Tongana, T., ElSheikh, W., Lindeman, J., McQueen, M., Hall, K., Keys, J., Wang, X., Keneth, J., Devanath, A., Diaz, R., Orlandini, A., Linetsky, B., Toscanelli, S., Casaccia, G., Maini Cuneo, J., Rahman, O., Yusuf, R., Azad, A., Rabbani, K., Cherry, H., Mannan, A., Hassan, I., Talukdar, A., Tooheen, R., Khan, M., Sintaha, M., Choudhury, T., Haque, R., Parvin, S., Avezum, A., Oliveira, G., Marcilio, C., Mattos, A., Teo, K., Yusuf, S., Dejesus, J., Agapay, D., Tongana, T., Solano, R., Kay, I., Trottier, S., Rimac, J., Elsheikh, W., Heldman, L., Ramezani, E., Dagenais, G., Poirier, P., Turbide, G., Auger, D., De Bluts, A. L., Proulx, M., Cayer, M., Bonneville, N., Lear, S., Gasevic, D., Corber, E., de Jong, V, Vukmirovich, I., Wielgosz, A., Fodor, G., Pipe, A., Shane, A., Lanas, F., Seron, P., Martinez, S., Valdebenito, A., Oliveros, M., Wei, L., Lisheng, L., Chunming, C., Xingyu, W., Wenhua, Z., Hongye, Z., JiaXuan, Bo, H., Yi, S., Jian, B., Xiuwen, Z., Xiaohong, C., Tao, C., Hui, C., Xiaohong, C., Qing, D., Xiaoru, C., Qing, D., Xinye, H., Bo, H., JiaXuan, Jian, L., Juan, L., Xu, L., Bing, R., Yi, S., Wei, W., Yang, W., Jun, Y., Yi, Z., Hongye, Z., Xiuwen, Z., Manlu, Z., Fanghong, L., Jianfang, W., Yindong, L., Yan, H., Liangqing, Z., Baoxia, G., Xiaoyang, L., Shiying, Z., BianRongwen, TianXiuzhen, Dong, L., Di, C., Jianguo, W., Yize, X., Tianlu, L., Peng, Z., Changlin, D., Ning, L., Xiaolan, M., Yuqing, Y., Rensheng, L., Minfan, F., Jing, H., Yu, L., Xiaojie, X., Qiang, Z., Lopez-Jaramillo, P., Lopez, P. C., Garcia, R., Jurado, L., Gómez-Arbeláez, D., Arguello, J., Dueñas, R., Silva, S., Pradilla, L., Ramirez, F., Molina, D., Cure-Cure, C., Perez, M., Hernandez, E., Arcos, E., Fernandez, S., Narvaez, C., Paez, J., Sotomayor, A., Garcia, H., Sanchez, G., David, T., Rico, A., Mony, P., Vaz, M., Bharathi, A. V., Swaminathan, S., Shankar, K., Kurpad, A., Jayachitra, K., Kumar, N., Hospital, H., Mohan, V, Deepa, M., Parthiban, K., Anitha, M., Hemavathy, S., Rahulashankiruthiyayan, T., Anitha, D., Sridevi, K., Gupta, R., Panwar, R., Mohan, I., Rastogi, P., Rastogi, S., Bhargava, R., Kumar, R., Thakur, J. S., Patro, B., Lakshmi, P., Mahajan, R., Chaudary, P., Kutty, V. R., Vijayakumar, K., Ajayan, K., Rajasree, G., Renjini, A., Deepu, A., Sandhya, B., Asha, S., Soumya, H., Kelishadi, R., Bahonar, A., Mohammadifard, N., Heidari, H., Yusoff, K., Ismail, T., Ng, K., Devi, A., Nasir, N., Yasin, M., Miskan, M., Rahman, E., Arsad, M., Ariffin, F., Razak, S., Majid, F., Bakar, N., Yacob, M., Zainon, N., Salleh, R., Ramli, M., Halim, N., Norlizan, Sr., Ghazali, N., Arshad, M., Razali, R., Ali, S., Othman, H., Hafar, C., Pit, A., Danuri, N., Basir, F., Zahari, S., Abdullah, H., Arippin, M., Zakaria, N., Noorhassim, I., Hasni, M., Azmi, M., Zaleha, M., Hazdi, K., Rizam, A., Sazman, W., Azman, A., Khatib, R., Khammash, U., Khatib, A., Giacaman, R., Iqbal, R., Afridi, A., Khawaja, R., Raza, A., Kazmi, K., Dans, A., Co, H., Sanchez, J., Pudol, L., Zamora-Pudol, C., Palileo-Villanueva, L., Aquino, M., Abaquin, C., Pudol, S., Cabral, M., Zatonski, W., Szuba, A., Zatonska, K., Ilow#, R., Ferus, M., Regulska-Ilow, B., Różańska, D., Wolyniec, M., AlHabib, K., Hersi, A., Kashour, T., Alfaleh, H., Alshamiri, M., Altaradi, H., Alnobani, O., Bafart, A., Alkamel, N., Ali, M., Abdulrahman, M., Nouri, R., Kruger, A., Voster, H. H., Schutte, A. E., Wentzel-Viljoen, E., Eloff, F., de Ridder, H., Moss, H., Potgieter, J., Roux, A., Watson, M., de Wet, G., Olckers, A., Jerling, J., Pieters, M., Hoekstra, T., Puoane, T., Igumbor, E., Tsolekile, L., Sanders, D., Naidoo, P., Steyn, N., Peer, N., Mayosi, B., Rayner, B., Lambert, V, Levitt, N., Kolbe-Alexander, T., Ntyintyane, L., Hughes, G., Swart, R., Fourie, J., Muzigaba, M., Xapa, S., Gobile, N., Ndayi, K., Jwili, B., Ndibaza, K., Egbujie, B., Rosengren, A., Boström, K. B., Lindblad, U., Langkilde, P., Gustavsson, A., Andreasson, M., Snällman, M., Wirdemann, L., Pettersson, K., Moberg, E., Yeates, K., Sleeth, J., Kilonzo, K., Oguz, A., Akalin, A., Calik, K., Imeryuz, N., Temizhan, A., Alphan, E., Gunes, E., Sur, H., Karsidag, K., Gulec, S., Altuntas, Y., Yusufali, A., Almahmeed, W., Swidan, H., Darwish, E., Hashemi, A., Al-Khaja, N., Muscat-Baron, J., Ahmed, S., Mamdouh, T., Darwish, W., Abdelmotagali, M., Awed, S. O., Movahedi, G., Hussain, F., Shaibani, H. A., Gharabou, R., Youssef, D., Nawati, A., Salah, Z. A., Abdalla, R., Shuwaihi, S. A., Omairi, M. A., Cadigal, O., Alejandrino, R. S., Chifamba, J., Gwaunza, L., Terera, G., Mahachi, C., Murambiwa, P., Machiweni, T., & Mapanga, R.
Affiliations
  • London School of Hygiene & Tropical Medicine (GB)
  • Post Graduate Institute of Medical Education and Research (IN)
  • Dubai Health Authority (AE)
  • Health Action by People (IN)
  • Population Health Research Institute (CA)
  • The University of Sydney (AU)
  • Wroclaw Medical University (PL)
  • University of Gothenburg (SE)
  • Loyola University Medical Center (US)
  • Isfahan University of Medical Sciences (IR)
  • North-West University (ZA)
  • Madras Diabetes Research Foundation (IN)
  • UCSI University (MY)
  • Simon Fraser University (CA)
  • King Saud University (SA)
  • University of the Western Cape (ZA)
  • Istanbul Medeniyet University (TR)
Corresponding author
  • O'Donnell, M
  • Zhang, M
  • Dayal, L
  • Dehghan, M
  • Shifaly, F
  • Trottier, M
  • McQueen, M
  • Sintaha, M
  • Cayer, M
  • Oliveros, M
  • Wei, Li
  • Ning, Li
  • Ramirez, F
  • Perez, M
  • Vaz, M
  • Parthiban, K
  • Hemavathy, S
  • Rahman, EA
  • Razak, SA
  • Majid, FA
  • Zainon, N
  • Othman, HR
  • Zahari, SNA
  • Arippin, MA
  • Zamora-Pudol, C
  • Alshamiri, M
  • Altaradi, HB
  • Abdulrahman, M
  • Nouri, R
  • Moss, H
  • Potgieter, J
  • Hoekstra, T
  • Sanders, D
  • Hughes, G
  • Xapa, S
  • Snällman, M
  • Wirdemann, L
  • Pettersson, K
  • Karsidag, K
  • Darwish, EA
  • Shaibani, H Al
  • Terera, G
Venue
The Lancet Public Health
Publisher
Elsevier BV
Published
2017-09
Volume
2
Issue
9
Pages
e411-e419
ISSN
2468-2667 (ISSN-L)
OpenAlex
W2751849735
Cited by
209
References
37
Citations by year
2026: 17 · 2025: 23 · 2024: 27 · 2023: 21 · 2022: 23 · 2021: 29 · 2020: 34 · 2019: 17 · 2018: 17 · 2017: 1
FWCI
14.60
Type
journal article
Language
en
Open access
Licence
Locations
  • The Lancet Public Health (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Boloka Institutional Repository (North-west University) (submittedVersion)
Funders
  • AstraZeneca Canada
  • Boehringer Ingelheim
  • Indian Council of Medical Research
  • AFA Försäkring
  • Ministerstwo Nauki i Szkolnictwa Wyższego (290/W-PURE/2008/0)
  • Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010)
  • Deanship of Scientific Research, King Saud University (RG -1436-013)
  • South Africa Netherlands research Programme on Alternatives in Development
  • Svenska ForskningsrÃ¥det Formas
  • Universiti Teknologi MARA
  • North-West University
  • Ministry of Higher Education, Malaysia (600-RMI/LRGS/5/3 [2/2011)
  • Philippine Council for Health Research and Development
  • Heart and Stroke Foundation of Canada
  • Servier
  • International Development Research Centre
  • United Arab Emirates University
  • Canadian Institutes of Health Research
  • GlaxoSmithKline
  • ForskningsrÃ¥det för Arbetsliv och Socialvetenskap
  • Universidad de La Frontera
  • VetenskapsrÃ¥det
  • Public Health Agency of Canada
  • Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences
  • Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Healthcare Systems and Reforms
Keywords
hypertension, drug affordability, blood pressure control, combination therapy, generic drugs, economic development, PURE study, India, low-income countries, middle-income countries, high-income countries, cardiovascular risk factors, access to medicines
MeSH terms
Aged, Antihypertensive Agents, Developing Countries, Female, Humans, Hypertension, Income, Male, Middle Aged, Treatment Outcome, Developed Countries

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data. https://app.cochat.ai/papers/10.1016/s2468-2667(17)30141-x
The paper
Attaei, M. W., Khatib, R., McKee, M., Lear, S., Dagenais, G., Igumbor, E. U., AlHabib, K. F., Kaur, M., Kruger, L., Teo, K., Lanas, F., Yusoff, K., Oguz, A., Gupta, R., Yusufali, A. M., Bahonar, A., Kutty, R., Rosengren, A., Mohan, V., . . . Mapanga, R. (2017). Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data. The Lancet Public Health. https://doi.org/10.1016/s2468-2667(17)30141-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.